Study of the Characteristics of Acute Mycoplasma Resuscitation: ECRAN-PLASMA Study
NCT07479355 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-18
Summary
The ECRAN-PLASMA study aims to analyze the characteristics of patients with Mycoplasma pneumoniae or Chlamydia pneumoniae pneumonia hospitalized in intensive care units (ICU), continuous monitoring units (USC), or intensive pulmonary care units (USIP). It evaluates their management, prognosis, and macrolide resistance rates.
Conditions
Interventions
- OTHER
-
Infectious disease epidemiology
evaluation of patient management, prognosis, and macrolide resistance rates in severe Mycoplasma pneumoniae and Chlamydia pneumoniae infections.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-15
- Primary Completion
- 2024-09-15
- Completion
- 2026-06-15
Countries
- France
Study Locations
More Related Trials
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA
-
Exploratory Analysis of Pulmonary Microbiome in Intubated Patients
NCT03720093 ·Status: COMPLETED
-
Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department
NCT04786249 ·Status: COMPLETED
-
Etiology of Community Acquired Pneumonia
NCT00471757 ·Status: COMPLETED
-
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
NCT04500132 ·Status: COMPLETED ·Phase: PHASE2
-
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
NCT04359706 ·Status: COMPLETED
-
Characterization of Respiratory Microbiota in Susceptibility to Viral Respiratory Infections
NCT03600753 ·Status: UNKNOWN ·Phase: NA
-
Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease
NCT04803695 ·Status: UNKNOWN
-
Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath
NCT07352462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
NCT02047773 ·Status: COMPLETED ·Phase: PHASE4
-
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
NCT04488510 ·Status: UNKNOWN
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Patients Not Responding to Antibiotics in the Community
NCT00245427 ·Status: COMPLETED ·Phase: NA
-
Airway Microbiome of Patients With Protracted Bacterial Bronchitis
NCT07255430 ·Status: RECRUITING
-
Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers
NCT02888457 ·Status: COMPLETED ·Phase: NA
-
Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19
NCT04505631 ·Status: COMPLETED
-
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
NCT05405491 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non Invasive Diagnosis of Pneumocystis Pneumonia
NCT03613025 ·Status: COMPLETED ·Phase: NA
-
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023 ·Status: COMPLETED ·Phase: PHASE3
-
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
NCT06779344 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
NCT00768534 ·Status: COMPLETED
-
Study of the Impact of an Intervention Performed by a Clinical Pharmacist on Patients at Risk of Pneumococcal Infection at the End of Hospitalization
NCT04734925 ·Status: COMPLETED
-
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481 ·Status: RECRUITING
-
Lower Respiratory Tract Infections Managed in Primary Care in France
NCT07416266 ·Status: COMPLETED
-
Evaluation of Pathogenesis and Diagnosis of Mycoplasma Pneumoniae Community-acquired Pneumonia (CAP)
NCT03613636 ·Status: COMPLETED